Eracal Therapeutics

Risk score

57

Headquarters

Flag of SwitzerlandSwitzerland

EraCal Therapeutics Ltd. is an emerging biotechnology firm that originated from the University of Zurich and Harvard University. The business is privately owned by a group of investors with expertise in biotechnology, including BERNINA BioInvest, Redalpine, and UZH Life Sciences Fund. EraCal Therapeutics Ltd., a preclinical biotechnology company, was established as a spin-off from the University of Zurich and Harvard University, and focuses on developing innovative drugs to address various ailments.